type 2 diabetes GSK cardiovascular disease

GSK reports positive results from Harmony Outcomes albiglutide trial

GlaxoSmithKline (GSK) has reported positive results from the Phase lV Harmony Outcomes trial evaluating the effect of albiglutide on major…